Citation Impact
Citing Papers
Prediction of Postoperative Pulmonary Complications in a Population-based Surgical Cohort
2010 Standout
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
Toward a Consensus Definition for COPD Exacerbations
2000 Standout
Cystic fibrosis
2016 Standout
Eosinophilic Inflammation in Asthma
1990 Standout
Obliterative bronchiolitis after lung and heart-lung transplantation
1995
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Lung Transplantation Outcome in Cystic Fibrosis Patients With Previous Pneumothorax
2005
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Cystic Fibrosis Pulmonary Guidelines
2007
Chronic obstructive pulmonary disease
1988
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
Lung disease in cystic fibrosis—an updated concept
1990
Pneumothorax in Cystic Fibrosis
2005
Standardisation of spirometry
2005 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Pulmonary Disease Caused by Mycobacterium chelonae in a Heart-Lung Transplant Recipient with Obliterative Bronchiolitis
1989
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit
1993
Drug administration by jet nebulization
1998
Lung Transplantation: A Decade of Experience
1999
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Management of Lung Transplant Rejection
1993
Ulcerative and Plaque-Like Tracheobronchitis Due to Infection with Aspergillus in Patients with AIDS
1993
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Health inequalities in the early years: Is there equalisation in youth?
1997
General considerations for lung function testing
2005 Standout
Long‐term tobramycin aerosol therapy in cystic fibrosis
1989
Effect of nebulizer type and antibiotic concentration on device performance
1997
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
1999
Salmonella typhi uses CFTR to enter intestinal epithelial cells
1998 StandoutNatureNobel
Rational parameters for antibiotic therapy in patients with cystic fibrosis
1987
Interpretative strategies for lung function tests
2005 Standout
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Pneumothorax in cystic fibrosis: A 26-year experience
1989
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Armadillo Exposure Among Mexican-Born Patients with Lepromatous Leprosy
1987
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Cystic fibrosis: A review of pulmonary infections and interventions
1987
Cystic Fibrosis Pulmonary Guidelines
2013
Idiopathic Pulmonary Fibrosis
2001 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis
1993
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
2013 Standout
Mycobacterial Infections in Lung Transplant Recipients
1999
Impairment of Endothelium-Dependent Pulmonary-Artery Relaxation in Chronic Obstructive Lung Disease
1991
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis
1987
Immunologic Aspects of Cystic Fibrosis
1988
Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management
2003
Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis
1993
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis
2003
Technical Report: Precautions Regarding the Use of Aerosolized Antibiotics
2000
Ulcerative Tracheobronchitis after Lung Transplantation: A New Form of Invasive Aspergillosis
1991
Researching health inequalities in adolescents: The development of the Health Behaviour in School-Aged Children (HBSC) Family Affluence Scale
2008 Standout
BTS guidelines for the management of spontaneous pneumothorax
2003
Pseudomonas aeruginosa Population Structure Revisited
2009
Antimicrobial Therapy Against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia
1988
BTS guidelines for the management of spontaneous pneumothorax
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
The Effect of Purified Human Eosinophil Major Basic Protein on Mammalian Ciliary Activity 1– 3
1987
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
1999 Standout
Oxidative Stress in Chronic Obstructive Pulmonary Disease
1997 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?
1986
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Diagnosis and Treatment of Cystic Fibrosis
1984
Evaluation of jet nebulisers for use with gentamicin solution.
1985
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
1995 Standout
Economic Status and Health in Childhood: The Origins of the Gradient
2002 Standout
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
2000 StandoutNature
Aspergillus allergy and allergic bronchopulmonary aspergillosis in cystic fibrosis
1991
Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections
1996 Science
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
1993
Genetics of O-Antigen Biosynthesis inPseudomonas aeruginosa
1999
Value OF CT-Guided Fine Needle Aspiration in Solitary Pulmonary Nodules with Negative Fiberoptic Bronchoscopy
1994
ORAL CIPROFLOXACIN COMPARED WITH CONVENTIONAL INTRAVENOUS TREATMENT FOR PSEUDOMONAS AERUGINOSA INFECTION IN ADULTS WITH CYSTIC FIBROSIS
1987
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
1996
FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION
1983
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
1995
Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
1987
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
1993
Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis
1987
CT-Guided Cutting Needle Biopsy of Lung Lesions — Safety and Efficacy of an Out-patient Service
2000
Aspergillus fumigatusand Aspergillosis
1999 Standout
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment ofPseudomonas aeruginosa colonization in cystic fibrosis
1998
Antibacterial Therapy in Cystic Fibrosis
1988
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Pulmonary Disease Associated with Pseudomonas aeruginosa in Cystic Fibrosis: Current Status of the Host-Bacterium Interaction
1985
Lipopolysaccharide Endotoxins
2002 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Mediation of the Killing of Rough, Mucoid Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis by the Alternative Pathway of Complement
1984
Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis
1997
Nitric oxide as a secretory product of mammalian cells
1992 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa
1985
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Talc Poudrage in the Treatment of Spontaneous Pneumothoraces in Patients with Cystic Fibrosis
1986
Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.
1981
Characterization and Use of a DNA Probe as an Epidemiological Marker for Pseudomonas aeruginosa
1987
The Continuing Challenges of Leprosy
2006 Standout
Effect of Size and Disease on Estimated Deposition of Drugs Administered Using Jet Nebulization in Children With Cystic Fibrosis
2001
Role of Alginate O Acetylation in Resistance of MucoidPseudomonas aeruginosato Opsonic Phagocytosis
2001
Works of A Penketh being referenced
Heart and lung transplantation in patients with end stage lung disease.
1987
TRANSBRONCHIAL LUNG BIOPSY FOR THE DIAGNOSIS OF REJECTION IN HEART-LUNG TRANSPLANT PATIENTS
1988
The Relationship of Phenotype Changes in Pseudomonas aeruginosa to the Clinical Condition of Patients with Cystic Fibrosis 1, 2
1983
Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants.
1988
Use of percutaneous needle biopsy in the investigation of solitary pulmonary nodules.
1987
Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis
1983
AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSIS
1981
Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis
1986
Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
1984
Cystic fibrosis serum does not inhibit human ciliary beat frequency.
1983
Cystic fibrosis in adolescents and adults.
1987
A preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new Tuberculins amongst Ugandan adults
1976
Management of pneumothorax in adults with cystic fibrosis.
1982